NewsTRANSPLANTATION AND CELLULAR THERAPYWednesday, April 8, 2026 · April 8, 2026
A Significant Risk Factor for Post-Transplant Lymphoproliferative Disorder in Pediatric Recipients: Low CD3+CD4+ T Cell Count at 30 Days after Hematopoietic Stem Cell Transplantation.
WHY IT MATTERS
Recent peer-reviewed research on Complications after hematopoietic stem cell transplantation that may be relevant for patients and caregivers.
Post-transplant lymphoproliferative disorder (PTLD) is a potentially life-threatening complication that arises early after pediatric hematopoietic stem cell transplantation (HSCT), primarily due to post-transplant immunosuppression. However, there is still a lack of effective predictive factors for ...
ResearchPubMedComplications after hematopoietic stem cell transplantationHumansLymphoproliferative Disorders
Related conditions
Related news
Int J Circumpolar Health · -248 days ago
A population-based legacy study of myasthenia gravis in Iceland: insights from a small Arctic nation
Published in Int J Circumpolar Health. Hjaltason H et al.…
Ther Adv Rare Dis · -218 days ago
Could an outcome-based agreement be operationalized using real-world data from the Canadian Neuromuscular Disease Registry? Perspectives from an expert-led assessment in spinal muscular atrophy
Published in Ther Adv Rare Dis. Mitha A et al.…
Health Inf Sci Syst · -218 days ago
PhenoRareAI: Phenotype-based intelligent diagnosis for rare neuromuscular disorders of glycogen storage disease and spinal muscular atrophy
Published in Health Inf Sci Syst. Zhai W et al.…
Mol Ther Nucleic Acids · -50 days ago
The post-pandemic pivot: mRNA therapeutics enter the chronic rare disease arena
Published in Mol Ther Nucleic Acids. Giangrande PH et al.…